CARING BRANDS INC (CABR)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$1.26-0.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · CABR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 717.5% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of — · Company calendar date is not available
CABR — dividend update
Dated 2026-08-25
Entry into a Material Definitive Agreement. On August 21, 2026, Caring Brands, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (collectively, the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a private placement (the “Offering”): (i) up to 11,000 shares of the Company’s newly designated Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Prefer…
Why it matters: More PIPE offerings can give needed money for operations and growth.
Supportive ifCABR announces a new PIPE offering. It raises a lot of money.
Worry ifNo new PIPE offerings are announced. This shows ongoing money problems.
Why it matters: The PIPE Offering can improve Caring Brands' finances. This affects stability and chances for growth.
Supportive ifCaring Brands completes the PIPE Offering and secures the funds.
Worry ifCaring Brands fails to close the PIPE Offering or faces delays.
Why it matters: New agreements can boost revenue and validate the company's product platforms. This is key for long-term growth.
Supportive ifRevenue from licensing agreements exceeds $1 million in the next quarter.
Worry ifRevenue from licensing agreements remains below $500,000 in the next quarter.
Why it matters: Completing this funding is key for marketing and salesforce expansion. It can boost revenue growth.
Supportive ifThe company will complete the last $4.4 million of the PIPE offering by September 4, 2026.
Worry ifThe company fails to complete the remaining PIPE offering by the expected date.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$417 on $10,000 · ±4.2% | How much price usually moves either way. |
| Bad day | $1,152 loss on $10,000 · 11.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,380 loss on $10,000 · 83.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The appeal outcome affects whether Caring Brands stays listed on Nasdaq. Losing the listing could hurt investor confidence.
Worry ifCaring Brands meets Nasdaq's requirement for stockholders' equity. They now have $2.5 million.
Less concerning ifCaring Brands fails to regain compliance and is delisted from Nasdaq.
Why it matters: Launching new products can drive growth and diversify revenue streams. It shows commitment to innovation.
Supportive ifThe company successfully launches at least two new products by the end of 2027.
Worry ifThe company delays or cancels planned product launches within the next year.
Why it matters: A better capital setup can make finances stronger and draw in investors.
Supportive ifManagement announces a new financing plan or debt changes that help the balance sheet.
Worry ifNo changes happen, or management says there are issues with the capital setup.
Why it matters: Strong leaders help set the right path. Uncertainty can lower investor trust.
Worry ifManagement names a new CEO or key leaders with good experience.
Less concerning ifThere are delays in filling key roles or more leaders leave.
Why it matters: Changes in leadership can affect how the company runs and its plans.
Watch forA new CFO or other key executive roles are announced.
Also watch forNo news on executive roles or interim leaders for over two quarters.
Why it matters: The appeal outcome changes the company's listing. It also impacts how investors feel.
Worry ifThe company meets Nasdaq Listing Rule 5550(b) again.
Less concerning ifThe appeal is denied, leading to delisting from Nasdaq.
Why it matters: New agreements can significantly increase revenue and market presence. It shows growth potential.
Supportive ifThe company reports higher revenue from Hair Enzyme Booster and Photocil in Q3 2026.
Worry ifRevenue from these products remains flat or declines in Q3 2026.
Why it matters: Regaining compliance is important to keep the company's Nasdaq listing. It affects investor trust.
Worry ifThe company wins the appeal against the Nasdaq delisting decision by the end of Q3 2026.
Less concerning ifThe Nasdaq confirms the delisting decision. This leads to removal from the exchange.
Why it matters: Strong sales growth shows that the market accepts the product. It also proves the product works.
Supportive ifSales of Hair Enzyme Booster grow a lot in quarterly reports.
Worry ifSales of Hair Enzyme Booster decline or stagnate in quarterly reports.
Why it matters: New patents help the company compete. They also aid in selling products.
Supportive ifThe company shares news about new patent filings or gets approvals for more patents.
Worry ifNo new patents are filed or approved in the next reporting period.
Why it matters: The company is below the $2.5 million equity requirement. This affects its Nasdaq listing.
Worry ifStockholders' equity goes above $2.5 million by the next report.
Less concerning ifStockholders' equity stays below $2.5 million or goes down more.
Why it matters: New patents can help the company in the market. They also aid in selling products.
Supportive ifThe company announces the issuance of at least two additional patents in the next quarter.
Worry ifNo new patents are issued or announced in the next quarter.